Biohaven Ltd. (BHVN) Q1 2021 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Biohaven Ltd..

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:00.029 -- 00:00:06.372 Good morning. Welcome to the BioHaven Pharmaceuticals Q1 2021 earnings 00:00:06.372 -- 00:00:12.455 call. At this time, all participant lines are in a listen-only mode. 00:00:12.455 -- 00:00:16.958 After the speaker's presentation, there will be a question and answer session. 00:00:16.958 -- 00:00:21.420 If anyone should require operator assistance during the conference, please press star 00:00:21.420 -- 00:00:24.081 zero on your telephone keypad. 00:00:24.081 -- 00:00:28.803 Please be advised that today's conference call may be recorded. 00:00:28.803 -- 00:00:32.746 I would now like to hand the conference over to Clifford Bechtold from Biohaven. 00:00:32.746 -- 00:00:35.928 Biohaven, thank you, and please go ahead. 00:00:35.928 -- 00:00:39.370 Thank you, and good morning to everybody. And welcome to the Biohaven first quarter 2021 00:00:39.370 -- 00:00:43.512 earnings call. Speaking on today's call are Dr. 00:00:43.512 -- 00:00:48.876 Vlad Torch, our chief executive officer, Jim Englehart, chief financial officer, BJ 00:00:48.876 -- 00:00:55.599 Jones, chief commercial officer, and Dr. Elise Stock, our chief medical officer. 00:00:55.751 -- 00:00:59.874 Earlier this morning, we issued a press release announcing the first quarter of 2021 00:00:59.874 -- 00:01:05.418 highlights. A copy of this press release can be found on our website at biohavenfarmer.com, 00:01:05.418 -- 00:01:10.081 and we will file our Form 10-Q later today. 00:01:10.081 -- 00:01:13.824 Before we begin, let me remind everybody that today's discussion contains forward-looking 00:01:13.824 -- 00:01:19.148 statements based on the environment as we currently see it, and includes risks and uncertainties. 00:01:19.148 -- 00:01:22.631 A list and description of the risk...